<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">16030</article-id><article-id pub-id-type="doi">10.7554/eLife.16030</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>Regulation of alternative polyadenylation by Nkx2-5 and Xrn2 during mouse heart development</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-53369"><name><surname>Nimura</surname><given-names>Keisuke</given-names></name><aff><institution content-type="dept">Division of Gene Therapy Science</institution>, <institution>Osaka University Graduate School of Medicine</institution>, <addr-line><named-content content-type="city">Suita</named-content></addr-line>, <country>Japan</country><email>nimura@gts.med.osaka-u.ac.jp</email></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-53694"><name><surname>Yamamoto</surname><given-names>Masamichi</given-names></name><aff><institution content-type="dept">Department of Nephrology</institution>, <institution>Kyoto University Graduate School of Medicine</institution>, <addr-line><named-content content-type="city">Kyoto</named-content></addr-line>, <country>Japan</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-53695"><name><surname>Takeichi</surname><given-names>Makiko</given-names></name><aff><institution content-type="dept">Division of Gene Therapy Science</institution>, <institution>Osaka University Graduate School of Medicine</institution>, <addr-line><named-content content-type="city">Suita</named-content></addr-line>, <country>Japan</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-53696"><name><surname>Saga</surname><given-names>Kotaro</given-names></name><aff><institution content-type="dept">Division of Gene Therapy Science</institution>, <institution>Osaka University Graduate School of Medicine</institution>, <addr-line><named-content content-type="city">Suita</named-content></addr-line>, <country>Japan</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-53697"><name><surname>Takaoka</surname><given-names>Katsuyoshi</given-names></name><aff><institution content-type="dept">Developmental Genetics Group</institution>, <institution>Osaka University</institution>, <addr-line><named-content content-type="city">Suita</named-content></addr-line>, <country>Japan</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-53698"><name><surname>Kawamura</surname><given-names>Norihiko</given-names></name><aff><institution content-type="dept">Division of Gene Therapy Science</institution>, <institution>Osaka University Graduate School of Medicine</institution>, <addr-line><named-content content-type="city">Suita</named-content></addr-line>, <country>Japan</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-53699"><name><surname>Nitta</surname><given-names>Hirohisa</given-names></name><aff><institution content-type="dept">Division of Gene Therapy Science</institution>, <institution>Osaka University Graduate School of Medicine</institution>, <addr-line><named-content content-type="city">Suita</named-content></addr-line>, <country>Japan</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-53700"><name><surname>Nagano</surname><given-names>Hiromichi</given-names></name><aff><institution content-type="dept">Division of Gene Therapy Science</institution>, <institution>Osaka University Graduate School of Medicine</institution>, <addr-line><named-content content-type="city">Suita</named-content></addr-line>, <country>Japan</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-53701"><name><surname>Ishino</surname><given-names>Saki</given-names></name><aff><institution content-type="dept">Center for Medical Research and Education</institution>, <institution>Osaka University Graduate School of Medicine</institution>, <addr-line><named-content content-type="city">Suita</named-content></addr-line>, <country>Japan</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-53702"><name><surname>Tanaka</surname><given-names>Tatsuya</given-names></name><aff><institution content-type="dept">Center for Medical Research and Education</institution>, <institution>Osaka University Graduate School of Medicine</institution>, <addr-line><named-content content-type="city">Suita</named-content></addr-line>, <country>Japan</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-53703"><name><surname>Schwartz</surname><given-names>Robert J</given-names></name><aff><institution content-type="dept">Department of Biology and Biochemistry</institution>, <institution>University of Houston</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-53704"><name><surname>Aburatani</surname><given-names>Hiroyuki</given-names></name><aff><institution content-type="dept">Genome Science Division</institution>, <institution>The University of Tokyo</institution>, <addr-line><named-content content-type="city">Tokyo</named-content></addr-line>, <country>Japan</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-53705"><name><surname>Kaneda</surname><given-names>Yasufumi</given-names></name><aff><institution content-type="dept">Division of Gene Therapy Science</institution>, <institution>Osaka University Graduate School of Medicine</institution>, <addr-line><named-content content-type="city">Suita</named-content></addr-line>, <country>Japan</country></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1166"><name><surname>Proudfoot</surname><given-names>Nick J</given-names></name><role>Reviewing editor</role><aff><institution>University of Oxford</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>22</day><month>06</month><year>2016</year></pub-date><elocation-id>e16030</elocation-id><supplementary-material><ext-link xlink:href="elife-16030-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>14</day><month>03</month><year>2016</year></date><date date-type="accepted"><day>21</day><month>06</month><year>2016</year></date></history><permissions><copyright-statement>Â© 2016, Nimura et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Nimura et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Transcription factors organize gene expression profiles by regulating promoter activity. However, the role of transcription factors after transcription initiation is poorly understood. Here, we show that the homeoprotein Nkx2-5 and the 5'-3' exonuclease Xrn2 are involved in the regulation of alternative polyadenylation (APA) during mouse heart development. Nkx2-5 occupied not only the transcription start sites (TSSs) but also the downstream regions of genes, serving to connect these regions in primary embryonic cardiomyocytes (eCMs). Nkx2-5 deficiency affected Xrn2 binding to target loci and resulted in increases in RNA polymerase II (RNAPII) occupancy and in the expression of mRNAs with long 3'untranslated regions (3' UTRs) from genes related to heart development. siRNA-mediated suppression of Nkx2-5 and Xrn2 led to heart looping anomaly. Moreover, <italic>Nkx2-5</italic> genetically interacts with <italic>Xrn2</italic> because <italic>Nkx2-5</italic><sup>+/-</sup><italic>Xrn2</italic><sup>+/-</sup>, but neither <italic>Nkx2-5<sup>+/-</sup></italic> nor <italic>Xrn2<sup>+/-</sup></italic>, newborns exhibited a defect in ventricular septum formation, suggesting that the association between Nkx2-5 and Xrn2 is essential for heart development. Our results indicate that Nkx2-5 regulates not only the initiation but also the usage of poly(A) sites during heart development. Our findings suggest that tissue-specific transcription factors is involved in the regulation of APA.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: The protocols (3422-1 and 24-084-012) are approved by the Ethics Committee for Animal Experiments of the Osaka University Graduate School of Medicine.with protocols</p></fn></fn-group></back></article>